Apontis Pharma Valuation Multiples
Discover revenue and EBITDA valuation multiples for Apontis Pharma.
Apontis Pharma Overview
About Apontis Pharma
Apontis Pharma AG is a pharmaceutical company specializing in single pills in Germany. single pills combine two to three generic active ingredients in a single dosage form. The company develops, promotes, and sells a broad portfolio of single pills and other pharmaceutical products, with a special focus on cardiovascular diseases. The company markets drugs in the disease areas of respiratory diseases and diabetes as part of co-marketing/co-promotion.
Founded
1946
HQ
Employees
137
Website
Financials (FY)
EV
$87M
Valuation Multiples
Start free trial
Apontis Pharma Stock Performance
Apontis Pharma has current market cap of $105M, and enterprise value of $87M.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $87M | $105M | - | - | - | - | - |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialApontis Pharma Valuation Multiples
Apontis Pharma Financial Valuation Multiples
As of August 17, 2026, Apontis Pharma has market cap of $105M and EV of $87M.
| LTM | Last FY | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Apontis Pharma Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Apontis Pharma Competitors
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
This data is available for Pro users. Sign up to see all Apontis Pharma competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Apontis Pharma
| When was Apontis Pharma founded? | Apontis Pharma was founded in 1946. |
| Where is Apontis Pharma headquartered? | Apontis Pharma is headquartered in Germany. |
| How many employees does Apontis Pharma have? | As of today, Apontis Pharma has over 137 employees. |
| Is Apontis Pharma publicly listed? | Yes, Apontis Pharma is a public company listed on Düsseldorf Stock Exchange. |
| What is the stock symbol of Apontis Pharma? | Apontis Pharma trades under APPH ticker. |
| When did Apontis Pharma go public? | Apontis Pharma went public in 2021. |
| Who are competitors of Apontis Pharma? | Apontis Pharma main competitors include |
| What is the current market cap of Apontis Pharma? | Apontis Pharma's current market cap is $105M. |
| Is Apontis Pharma profitable? | No, Apontis Pharma is not profitable. |
| How many companies Apontis Pharma has acquired to date? | Apontis Pharma hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Apontis Pharma has invested to date? | Apontis Pharma hasn't invested in any companies yet (or none have been disclosed publicly). |
Lists including Apontis Pharma
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.